Drug Registration in Russia and the EAEU

OCT CRO provides end-to-end drug registration and clinical trial support in Russia and the Eurasian Economic Union (EAEU) countries. We help pharmaceutical and biotech companies enter new, fast-growing markets by navigating complex regulatory pathways and local requirements.

Book a consultation

Why the EAEU Market?

Marketing authorization
in 1 country
=
Marketing authorization
in 5 countries
EAEU map

The EAEU is a single regulatory space for pharmaceuticals, offering drugs access to EAEU countries' market faster and simplified through one coordinated framework.

Russia
Armenia
Belarus
Kazakhstan
Kyrgyzstan
Total population: 186 million people
(~2.5% of the world's population)

OCT provides a full range of services for the marketing authorization of medicines in Russia and EAEU countries, for both local and International Sponsors.

  • Validation of the sponsor's dossier and gap analysis. Development of drugs/APIs registration strategy.
  • Preparation of registration dossiers in eCTD format.
  • eCTD dossier conversion into XML.
  • Development of EAEU eCTD Module 2 (Sections 2.3–2.7).
  • Normative document development in acc. with EAEU requirements or local legislation.
  • Development of Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL)/Instructions for medical use.
  • Conducting PIL user testing.
  • Development of packaging mockups.
  • Arrangement of sample import for pharmaceutical examination.
  • Organization of the comparative dissolution kinetics test.
  • Translation, revision, and notary certification of all necessary documentation.
  • GMP inspection.
  • Pharmacovigilance.
  • Organization and conducting of local pre-clinical and clinical studies required for drug registration.
  • Registration and re-registration of the maximum-selling price.
Send an RFP

Drug Registration in the EAEU: How It Works

GMP Inspection ~ 11 months
Dossier submission to
Reference country
Dossier expertise by
Reference country
Obtaining Marketing Authorization
Reference country
Recognition by other EAEU countries
based on country-specific Module 1 and review of the reference country Expertise report

Steps 1-3: 11 months-1.5 year (140 working days expertise + stop times for applicant's replies)

Step 4: ≈ 8 months
(100 working days expertise+
stop times for applicant's replies)

OCT CRO supports sponsors at every stage of this process.

Book a consultation

Why Chinese Companies Choose OCT CRO

  • Proven experience in Russia & EAEU regulatory systems
  • Local presence and strong relationships with authorities
  • Expertise in bridging Chinese development data with EAEU requirements
  • Full CRO capabilities: regulatory, clinical, operational
  • Clear timelines and transparent communication
Russia and China
Conference 1 Conference 2

Ready to Enter the EAEU Market?

Whether you are planning your first registration or expanding an existing portfolio, OCT CRO will guide you every step of the way.

Send an RFP
Contact OCT
Thanks! Your message has been sent successfully!
An error has occurred. Try sending the message again or contact us in another way.